Gonorrhea prevention and clinical care in the private sector: Lessons learned and priorities for quality improvement

Sexually Transmitted Diseases

Volumn 33, Issue 11, 2006, Pages 652-662

  Tao, Guoyu ^a   Irwin, Kathleen L ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; CLINICAL PRACTICE; CONTROLLED STUDY; COUNSELING; DIAGNOSTIC TEST; EMERGENCY WARD; FEMALE; GONORRHEA; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MEDICAL CARE; MEDICAL RECORD; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; PREGNANT WOMAN; PROPHYLAXIS; QUALITY CONTROL; REVIEW; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE;

DIAGNOSTIC TESTS, ROUTINE; FEMALE; GONORRHEA; HUMANS; MALE; MASS SCREENING; NEISSERIA GONORRHOEAE; PREVALENCE; PRIVATE PRACTICE; QUALITY ASSURANCE, HEALTH CARE; SEROLOGIC TESTS; UNITED STATES;

EID: 33750351018     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000216030.65618.0e     Document Type: Review

References (110)

1. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR Morb Mortal Wkly Rep 2002; 51:1-78.
2. Hook EW. Gonococcal Infections in the Adult. New York: McGraw-Hill, 2004.
3. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2000. Atlanta: Department of Health and Human Services, Centers for Disease Control and Prevention, 2004.
4. Brackbill RM, Sternberg MR, Fishbein M. Where do people go for treatment of sexually transmitted diseases? Fam Plann Perspect 1999; 31:10-15.
5. The Henry J. Kaiser Family Foundation. The Kaiser Commission on Medicaid and the uninsured. Menlo Park: The Henry J. Kaiser Foundation, 2003.
6. Centers for Disease Control and Prevention. HIV/STD risk in young men who have sex with men do not disclose their sexual orientation - six US cities, 1994-2000. MMWR Morb Mortal Wkly Rep 2003; 52:81-86.
7. Eubanks C, Lafferty WE, Kimball AM, MacCornack R, Kassler WJ. Privatization of STD services in Tacoma, Washington: A quality review. Sex Transm Dis 1999; 26:537-542.
8. Randel L, Pearson SD, Sabin JE, Hyams T, Emanuel EJ. How managed care can be ethical. Health Aff (Millwood) 2001; 20:43-56.
9. Hurley RE, Somers SA. Medicaid and managed care: a lasting relationship? Health Aff (Millwood) 2003; 22:77-88.
10. Institute of Medicine. The Hidden Epidemic: Confronting Sexually Transmitted Disease. National Academy Press, 2004.
11. Centers for Disease Control and Prevention. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:1-38.
12. Henderson Z, Tao G, Irwin K. Sexually transmitted disease care in managed care organizations. Infect Dis Clin North Am 2005; 19:491-511.
13. Chorba T, Scholes D, BlueSpruce J, Operskalski BH, Irwin KL. Sexually transmitted diseases and managed care: An inquiry and review of issues affecting service delivery. Am J Med Qual 2004; 19:145-156.
14. Bachmann LH, Pigott D, Desmond R, et al. Prevalence and factors associated with gonorrhea and chlamydial infection in at-risk females presenting to an urban emergency department. Sex Transm Dis 2003; 30:335-339.
15. Best D, Ford CA, Miller WC. Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infection in pediatric private practice. Pediatrics 2001; 108:E103.
16. Boyer CB, Shafer MA, Teitle E, Wibbelsman CJ, Seeberg D, Schachter J. Sexually transmitted diseases in a health maintenance organization teen clinic: Associations of race, partner's age, and marijuana use. Arch Pediatr Adolesc Med 1999; 153:838-844.
17. Embling ML, Monroe KW, Oh MK, Hook EW III. Opportunistic urine ligase chain reaction screening for sexually transmitted diseases in adolescents seeking care in an urban emergency department. Ann Emerg Med 2000; 36:28-32.
18. Hoffman L, Ma OJ, Gaddis G, Schwab RA. Cervical infections in emergency department patients with vaginal bleeding. Acad Emerg Med 2002; 9:781-785.
19. Levitt MA, Johnson S, Engelstad L, Montana R, Stewart S. Clinical management of chlamydia and gonorrhea infection in a county teaching emergency department - Concerns in overtreatment, undertreatment, and follow-up treatment success. J Emerg Med 2003; 25:7-11.
20. Mahon BE, Rosenman MB, Graham MF, Fortenberry JD. Postpartum Chlamydia trachomatis and Neisseria gonorrhoeae infections. Am J Obstet Gynecol 2002; 186:1320-1325.
21. Mehta SD, Rothman RE, Kelen GD, Quinn TC, Zenilman JM. Unsuspected gonorrhea and chlamydia in patients of an urban adult emergency department: A critical population for STD control intervention. Sex Transm Dis 2001; 28:33-39.
22. Mertz KJ, Levine WC, Mosure DJ, Berman SM, Dorian KJ, Hadgu A. Screening women for gonorrhea: Demographic screening criteria for general clinical use. Am J Public Health 1997; 87:1535-1538.
23. Monroe KW, Weiss HL, Jones M, Hook EW III. Acceptability of urine screening for Neisseria gonorrhoeae and Chlamydia trachomatis in adolescents at an urban emergency department. Sex Transm Dis 2003; 30:850-853.
24. Todd CS, Haase C, Stoner BP. Emergency department screening for asymptomatic sexually transmitted infections. Am J Public Health 2001; 91:461-464.
25. Turner CF, Rogers SM, Miller HG, et al. Untreated gonococcal and chlamydial infection in a probability sample of adults. JAMA 2002;287:726-733.
26. Wiest DR, Spear SJ, Bartfield JM. Empiric treatment of gonorrhea and chlamydia in the ED. Am J Emerg Med 2001; 19:274-275.
27. Montes J, Tulloch R, Gould G, Bolan G, Dyer I, Richwald G. Clinical laboratory survey: A program management tool. National STD Prevention Conference, December 6-9, 1998. Dallas, Texas; Abstract # B7.
28. Datta SD, Sternberg M, Johnson RE, et al. Prevalence of chlamydia and gonorrhea in the United States among persons aged 14-39 years, 1999-2000. 2003 ISSTDR Congress, Ottawa, Canada, July 2004:27-30.
29. Miller WC, Ford CA, Morris M, et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA 2004; 291:2229-2236.
30. Jones CA, Knaup RC, Hayes M, Stoner BP. Urine screening for gonococcal and chlamydial infections at community-based organizations in a high-morbidity area. Sex Transm Dis 2000; 27:146-151.
31. Ebrahim SH, Andrews WW, Zaidi AA, Levine WC, DuBard MB, Goldenberg RL. Syphilis, gonorrhoea, drug abuse among pregnant women in Jefferson County, Alabama US, 1980-94: Monitoring trends through systematically collected health services data. Sex Transm Infect 1999; 75:300-305.
32. Thomas JC, Schoenbach VJ, Weiner DH, Parker EA, Earp JA. Rural gonorrhea in the southeastern United States: A neglected epidemic? Am J Epidemiol 1996; 143:269-277.
33. McGrath C, Rene A, Jones B, Sandhu R. Descriptive study of sexually transmitted diseases in Tarrant County, Texas, from 1998 through 2000. Texas Med 2003; 99:48-53.
34. Kahn RH, Moseley KE, Thilges JN, Johnson G, Farley TA. Community-based screening and treatment for STDs: Results from a mobile clinic initiative. Sex Transm Dis 2003; 30:654-658.
35. Wiesenfeld HC, Lowry DL, Heine RP, et al. Self-collection of vaginal swabs for the detection of chlamydia, gonorrhea, and trichomoniasis: Opportunity to encourage sexually transmitted disease testing among adolescents. Sex Transm Dis 2001; 28:321-325.
36. Cohen DA, Nsuami M, Martin DH, Farley TA. Repeated school-based screening for sexually transmitted diseases: A feasible strategy for reaching adolescents. Pediatrics 1999; 104:1281-1285.
37. Smith K, Harrington K, Wingood G, Oh MK, Hook EW III, DiClemente RJ. Self-obtained vaginal swabs for diagnosis of treatable sexually transmitted diseases in adolescent girls. Arch Pediatr Adolesc Med 2001; 155:676-679.
38. Burstein GR, Waterfield G, Joffe A, Zenilman JM, Quinn TC, Gaydos CA. Screening for gonorrhea and chlamydia by DNA amplification in adolescents attending middle school health centers. Opportunity for early intervention. Sex Transm Dis 1998; 25:395-402.
39. Lifson AR, Halcon LL, Hannan P, St. Louis ME, Hayman CR. Screening for sexually transmitted infections among economically disadvantaged youth in a national job training program. J Adolesc Health 2001; 28:190-196.
40. Pack RP, DiClemente RJ, Hook EW III, Oh MK. High prevalence of asymptomatic STDs in incarcerated minority male youth: A case for screening. Sex Transm Dis 2000; 27:175-177.
41. Gostin LO, Webber DW. HIV infection and AIDS in the public health and health care systems: The role of law and litigation. JAMA 1998; 279:1108-1113.
42. UCLA Center for Health Policy Research. Sexually Transmitted Disease Services in California's Medi-Cal Managed Care. Los Angeles: UCLA Center for Health Policy Research, 2004.
43. Pourat N, Brown ER, Razack N, Kassler W. Medicaid managed care and STDs: Missed opportunities to control the epidemic. Health Aff (Millwood) 2002; 21:228-239.
44. Barnes RS, Anderson LA, Weisbord JS, Koumans E, Toomey KE. Georgia prenatal care providers' perceptions of barriers to sexually transmitted disease screening. South Med J 2003; 96:845-849.
45. Pourat N, Rice T, Tai-Seale M, Bolan G, Nihalani. Association between physician compensation methods and delivery of guideline-concordant STD care: Is there a link? Am J Manag Care 2005; 11:426-432.
46. Making the Grade on Women's Health: A National and State-by-State Report Card. Washington, DC: National Women's Law Center, 2004.
47. Centers for Disease Control and Prevention. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae among men who have sex with men-United States, 2003, and revised recommendations for gonorrhea treatment, 2004. MMWR Morb Mortal Wkly Rep 2004; 53:335-338.
48. California Department of Health Services. California Gonorrhea Treatment Guidelines. Revised June 25, 2003.
49. National Conference of State Legislatures. Sexually Transmitted Diseases: A Policymaker's Guide and Summary of State Laws. National Conference of State Legislatures, Washington, DC, 1998.
50. Smurzynski M, Moran T, Nguyen TQ, et al. STD screening and diagnostic testing policies among primary care practices in Wake County, North Carolina. National STD Prevention Conference, San Diego, California, March 4-7, 2002; Abstract P100.
51. Diaz A, Neal WP, Nucci AT, Ludmer P, Bitterman J, Edwards S. Legal and ethical issues facing adolescent health care professionals. Mt Sinai J Med 2004; 71:181-185.
52. Reddy DM, Fleming R, Swain C. Effect of mandatory parental notification on adolescent girls' use of sexual health care services. JAMA 2002; 288:710-771.
53. Ford CA, Best D, Miller WC. The pediatric forum: Confidentiality and adolescents' willingness to consent to sexually transmitted disease testing. Arch Pediatr Adolesc Med 2001; 155:1072-1073.
54. Tao G, Irwin KL, Kassler WJ. Missed opportunities to assess sexually transmitted diseases in US adults during routine medical checkups. Am J Prev Med 2000; 18:109-114.
55. Talking About STDs With Health Professionals: Women's Experiences. Henry J. Kaiser Family Foundation, 1997.
56. St. Lawrence JS, Montano DE, Kasprzyk D, Phillips WR, Armstrong K, Leichliter JS. STD screening, testing, case reporting, and clinical and partner notification practices: A national survey of US physicians. Am J Public Health 2002; 92:1784-1788.
57. Lafferty WE, Downey L, Shields AW, Holan CM, Lind A. Adolescent enrollees in Medicaid managed care: The provision of well care and sexual health assessment. J Adolesc Health 2001; 28:497-508.
58. Fortenberry J, Bull S. Barrier to sexual history taking in Medicaid managed care settings. National STD Prevention Conference, December 6-9, 1998, Dallas, Texas; Abstract B1.
59. Shafer MA, Tebb KP, Pantell RH, et al. Effect of a clinical practice improvement intervention on chlamydial screening among adolescent girls. JAMA 2002; 288:2846-2852.
60. Bull SS, Rietmeijer C, Fortenberry JD, et al. Practice patterns for the elicitation of sexual history, education, and counseling among providers of STD services: Results from the gonorrhea community action project (GCAP). Sex Transm Dis 1999; 26:584-589.
61. Boekeloo BO, Schamus LA, Simmens SJ, Cheng TL, O'Connor K, D'Angelo LJ. A STD/HIV prevention trial among adolescents in managed care. Pediatrics 1999; 103:107-115.
62. Centers for Disease Control and Prevention. Evaluation of sexually transmitted disease control practices for male patients with urethritis at a large group practice affiliated with a managed care organization - Massachusetts, 1995-1997. MMWR Morb Mortal Wkly Rep 2001; 50:460-462.
63. Centers for Disease Control and Prevention. Reporting of laboratory-confirmed chlamydial infection and gonorrhea by providers affiliated with three large managed care organizations - United States, 1995-1999. MMWR Morb Mortal Wkly Rep 2002; 51:256-259.
64. The US Preventive Services Task Force. Guide to Clinical Preventive Services. Baltimore: Williams & Wilkins, 1996.
65. Gonorrhea and Chlamydial Infections. ACOG Technical Bulletin no. 190. Washington, DC: American College of Obstetricians and Gynecologists, 1994.
66. Guidelines for Adolescent Preventive Services (GAPS): Recommendations and Rationale. Chicago: American Medical Association, 1994.
67. Chapin K, Landers L, Dickinson M. Current trends in screening, treatment and prevention of Chlamydia trachomatis and Neisseria gonorrhoeae in the United States: A survey of healthcare and laboratory testing providers. National STD Prevention Conference, December 6-9, 1998, Dallas, Texas; Abstract B6.
68. Ramus RM, Sheffield JS, Mayfield JA, Wendel GD Jr. A randomized trial that compared oral cefixime and intramuscular ceftriaxone for the treatment of gonorrhea in pregnancy. Am J Obstet Gynecol 2001; 185:629-632.
69. Ingram DM, Miller WC, Schoenbach VJ, Everett VD, Ingram DL. Risk assessment for gonococcal and chlamydial infections in young children undergoing evaluation for sexual abuse. Pediatrics 2001; 107:E73.
70. Schroeder B, Tetlow P, Sanfilippo JS, Hertweck SP. Is there a seasonal variation in gonorrhea and chlamydia in adolescents? J Pediatr Adolesc Gynecol 2001; 14:25-27.
71. Mehta SD, Rothman RE, Kelen GD, Quinn TC, Zenilman JM. Clinical aspects of diagnosis of gonorrhea and chlamydia infection in an acute care setting. Clinic Infect Dis 2001; 32:655-659.
72. Weisbord JS, Koumans EH, Toomey KE, Grayson C, Markowitz LE. Sexually transmitted diseases during pregnancy: Screening, diagnostic, and treatment practices among prenatal care providers in Georgia. South Med J 2001; 94:47-53.
73. Ratelle S, Yokoe D, Whelan M, et al. Management of urethritis in health maintenance organization members receiving care at a multispecialty group practice in Massachusetts. Sex Transm Dis 2001; 28:232-235.
74. Ratelle S, Yokoe D, Blejan C, et al. Predictive value of clinical diagnostic codes for the CDC case definition of pelvic inflammatory disease (PID): Implications for surveillance. Sex Transm Dis 2003; 30:866-870.
75. Kirsch TD, Shesser R, Barron M. Disease surveillance in the ED: Factors leading to the underreporting of gonorrhea. Am J Emerg Med 1998; 16:137-140.
76. Kane B. Compliance with the Centers for Disease Control and Prevention recommendations for the diagnosis and treatment of sexually transmitted diseases. Acad Emerg Med 2004; 11:371-377.
77. Mark KE, Gunn RA. Gonorrhea surveillance: Estimating epidemiologic and clinical characteristics of reported cases using a sample survey methodology. Sex Transm Dis 2004; 31:215-220.
78. Bull SS, Jones CA, Granberry-Owens D, Stoner BP, Rietmeijer CA. Acceptability and feasibility of urine screening for chlamydia and gonorrhea in community organizations: perspectives from Denver and St. Louis. Am J Public Health 2000; 90:285-286.
79. Chaney H, Chartier M, Bauer H, et al. Gonorrhea screening practices, strategies, and guideline development for non-pregnant female patients in a managed care setting. National STD Prevention Conference, San Diego, California, March 4-7, 2002; Abstract P17.
80. HEDIS Technical Specifications. Washington, DC: National Committee for Quality Assurance, 2004.
81. Tao G, Walsh CM, Anderson LA, Irwin KL. Avenues to combat the silent epidemic of chlamydia infection in managed care organizations: An analysis of the HEDIS measure on screening for Chlamydia trachomatis. Prev Med Managed Care 2000; 1:177-183.
82. Burstein G, Snyder MH, Conley D, et al. Chlamydia screening in a health plan before and after a national performance measure introduction. Obset Gynecol 2005; 106:327-334.
83. USPSTF. Screening for Gonorrhea: Recommendation Statement. Rockville, MD: Agency for Healthcare Research and Quality, 2005.
84. Scholes D, Anderson LA, Operskalski BH, BlueSpruce J, Irwin K, Magid DJ. STD prevention and treatment guidelines: A review from a managed care perspective. Am J Managed Care 2003; 9:181-189.
85. Goodman CS. Healthcare technology assessment: Methods, framework, and role in policy making. Am J Managed Care 1998; 4:Spec-14.
86. Wiesenfeld HC, Zamborshy T, Krohn MJ, Cook RL, Ashton MR, Scholle S. Management of sexually transmitted diseases by primary care physicians. National STD Prevention Conference, December 6-9, 1998, Dallas, Texas; Abstract 36.
87. Minnesota Department of Health Services. 2003 External Quality Review: Sexually Transmitted Diseases - Prevention, Screening, and Treatment of STDs in Minnesota Publicly Funded Managed Care Programs. Minnesota Department of Health Services, 2004.
88. Gunn RA, Rolfs RT, Greenspan JR, Seidman RL, Wasserheit JN. The changing paradigm of sexually transmitted disease control in the era of managed health care. JAMA 1998; 279:680-684.
89. Cates JR, Alexander L, Cates W Jr. Prevention of sexually transmitted diseases in an era of managed care: The relevance for women. Womens Health Issues 1998; 8:169-186.
90. Mullooly JP, Valanis B, Maher JE, Vuckovic NA, Slepack J, Cooksey SG, Easter K, Stevens NH, Irwin K, Dixon J, Anderson LA. Improving services for sex partners of chlamydia-infected patients in an HMO. Am J Managed Care 2005; 11:609-618.
91. Hessol NA, Priddy FH, Bolan G, et al. Management of pelvic inflammatory disease by primary care physicians. A comparison with Centers for Disease Control and Prevention guidelines. Sex Transm Dis 1996; 23:157-163.
92. Yealy DM, Greene TJ, Hobbs GD. Underrecognition of cervical Neisseria gonorrhoeae and Chlamydia trachomatis infections in the emergency department. Acad Emerg Med 1997; 4:962-967.
93. Kelly JJ, Dalsey WC, McComb J, Njuki F. Follow-up program for emergency department patients with gonorrhea or chlamydia. Acad Emerg Med 2000; 7:1437-1439.
94. Magid DJ, Stiffman M, Anderson LA, Irwin K, Lyons EE Adherence to CDC STD guideline recommendations for the treatment of Chlamydia trachomatis infection in two managed care organizations Sex Transm Dis 2003; 30:30-32.
95. American Academy of Pediatrics Committee on Adolescence. Sexually transmitted diseases. Pediatrics 1994; 94:t-72.
96. Kurth A, Bielinski L, Graap K, Conniff J, Connell FA. Reproductive and sexual health benefits in private health insurance plans in Washington State. Fam Plann Perspect 2001; 33:153-160.
97. McCree DH, Liddon NC, Hogben M, St. Lawrence JS. National survey of doctors' actions following the diagnosis of a bacterial STD. Sex Transm Infect 2003; 79:254-256.
98. Tao G, Branson BM, Anderson LA, Irwin KL. Do physicians provide counseling with HIV and STD testing at physician offices or hospital outpatient departments? AIDS 2003; 17:1243-1247.
99. Mark H, Stiffman M, Magid D, Irwin K. Self-reported barriers to sexually transmitted diseases care among providers in two large health plans. Sex Transm Dis. In press.
100. Cardonick E, Daly S, Dooley M, Elles K, Silverman NS. Determinants of antepartum human immunodeficiency virus testing in a non-Medicaid obstetric population. Infect Dis Obstet Gynecol 1998; 6:209-213.
101. Golden MR, Hogben M, Handsfield HH, St. Lawrence JS, Potterat JJ, Holmes KK. Partner notification for HIV and STD in the United States: Low coverage for gonorrhea, chlamydial infection, and HIV. Sex Transm Dis 2003; 30:490-549.
102. Oh MK, Boker JR, Genuardi FJ, Cloud GA, Reynolds J, Hodgens JB. Sexual contact tracing outcome in adolescent chlamydial and gonococcal cervicitis cases. J Adolesc Health 1996; 18:4-9.
103. Golden MR, Whittington WL, Handsfield HH, et al. Partner management for gonococcal and chlamydial infection: Expansion of public health services to the private sector and expedited sex partner treatment through a partnership with commercial pharmacies. Sex Transm Dis 2001; 28:658-665.
104. Maher JE, Peterson J, Hastings K, et al. Partner violence, partner notification, and women's decisions to have an HIV test. J Acquir Immun Defic Syndr 2000; 25:276-282.
105. Eng TR. Prevention of sexually transmitted diseases. A model for overcoming barriers between managed care and public health. The IOM Workshop on the Role of Health Plans in STD Prevention. Am J Prev Med 1999; 16:60-69.
106. Lafferty WE, Kimball AM, Bolan G, Handsfield HH. Medicaid managed care and STD prevention: Opportunities and risks. J Public Health Manag Practice 1998; 4:52-58.
107. Roush S, Birkhead G, Koo D, Cobb A, Fleming D. Mandatory reporting of diseases and conditions by health care professionals and laboratories. JAMA 1999; 282:164-170.
108. Smucker DR, Thomas JC. Evidence of thorough reporting of sexually transmitted diseases in a southern rural county. Sex Transm Dis 1995; 22:149-145.
109. Chow JM, Montes J, Vugia D, et al. Pilot study of electronic STD data transmission between a HMO and a state STD control program. National STD Prevention Conference, December 6-9, 1998, Dallas, Texas; Abstract B1.
110. Bluespruce J, Dodge WT, Grothaus L, et al. HIV prevention in primary care: Impact of a clinical intervention. AIDS Pat Care and STDs 2001; 15:243-253.